Literature DB >> 27763684

Incidence, risk factors and clinical implications of chyle leak after pancreatic surgery.

O Strobel1, S Brangs1, U Hinz1, T Pausch1, F J Hüttner1, M K Diener1, L Schneider1, T Hackert1, M W Büchler1.   

Abstract

BACKGROUND: Chyle leak is a well known but poorly characterized complication after pancreatic surgery. Available data on incidence, risk factors and clinical significance of chyle leak are highly heterogeneous.
METHODS: For this cohort study all patients who underwent pancreatic surgery between January 2008 and December 2012 were identified from a prospective database. Chyle leak was defined as any drainage output with triglyceride content of 110 mg/dl or more. Risk factors for chyle leak were assessed by univariable and multivariable analyses. The clinical relevance of chyle leak was evaluated using hospital stay and resolution by 14 days for short-term outcome and overall survival for long-term outcome.
RESULTS: Chyle leak developed in 346 (10·4 per cent) of 3324 patients. Pre-existing diabetes, resection for malignancy, distal pancreatectomy, duration of surgery 180 min or longer, and concomitant pancreatic fistula or abscess were independent risk factors for chyle leak. Both isolated chyle leak and coincidental chyle leak (with other intra-abdominal complications) were associated with prolonged hospital stay. Some 178 (87·7 per cent) of 203 isolated chyle leaks and 90 (70·3 per cent) of 128 coincidental chyle leaks resolved with conservative management within 14 days. Initial and maximum drainage volumes were associated with duration of hospital stay and success of therapy by 14 days. Impact on survival was restricted to chyle leaks that persisted at 14 days in patients with cancer undergoing palliative surgery.
CONCLUSION: Chyle leak is a relevant complication, with an incidence of more than 10 per cent after pancreatic surgery, and has a major impact on hospital stay. Drainage volume is associated with hospital stay and success of therapy.
© 2016 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27763684     DOI: 10.1002/bjs.10316

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Delayed post-pancreatectomy hemorrhage and bleeding recurrence after percutaneous endovascular treatment: risk factors from a bi-centric study of 307 consecutive patients.

Authors:  Georges Farvacque; Théophile Guilbaud; Anderson Dieudonné Loundou; Ugo Scemamma; Stéphane Victor Berdah; Vincent Moutardier; Mircea Chirica; Olivier Risse; Edouard Girard; David Jérémie Birnbaum
Journal:  Langenbecks Arch Surg       Date:  2021-03-24       Impact factor: 3.445

2.  Risk factors and microbial spectrum for infectious complications after pancreaticoduodenectomy.

Authors:  Xu Fu; Yifei Yang; Liang Mao; Yudong Qiu
Journal:  Gland Surg       Date:  2021-12

Review 3.  Incidence and risk factors for Chyle leak after pancreatic surgery for cancer: A comprehensive systematic review.

Authors:  Milena Muzzolini; Raphael L C Araujo; T Peter Kingham; Frédérique Peschaud; François Paye; Renato M Lupinacci
Journal:  Eur J Surg Oncol       Date:  2021-12-03       Impact factor: 4.424

4.  Daily Triglyceride Output Volume as an Early Predictor for Chyle Leak Following Pancreaticoduodenectomy.

Authors:  Taro Sakamoto; Norimitsu Okui; Fumitake Suzuki; Ryoga Hamura; Yoshihiro Shirai; Koichiro Haruki; Kenei Furukawa; Toru Ikegami
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  Hepatic lymphorrhea following pancreaticoduodenectomy: Preliminary diagnosis and treatment experience from case series of four patients.

Authors:  Thanh Khiem Nguyen; Tuan Hiep Luong; Ngoc Cuong Nguyen; Ham Hoi Nguyen; Van Khang Le; Hong Son Trinh; Hai Dang Do; Van Duy Le; Ngoc Hung Nguyen
Journal:  Ann Med Surg (Lond)       Date:  2021-07-29

6.  Management of chylous ascites following pancreaticobiliary surgery.

Authors:  Harjeet Singh; Narendra Pandit; Gautham Krishnamurthy; Rajesh Gupta; Ganga R Verma; Rajinder Singh
Journal:  JGH Open       Date:  2019-04-24

7.  Successful management of chylous ascites after pancreatoduodenectomy using etilefrine: a case report.

Authors:  Yusuke Takahashi; Hitoshi Seki
Journal:  Oxf Med Case Reports       Date:  2020-02-28

Review 8.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

9.  Successful minimal invasive treatment of chylous ascites following pancreaticoduodenectomy: A case report and review of literature.

Authors:  Thanh Khiem Nguyen; Tuan Hiep Luong; Ngoc Cuong Nguyen; Ham Hoi Nguyen; Ngoc Hung Nguyen; Hong Son Trinh
Journal:  Ann Med Surg (Lond)       Date:  2021-05-28

10.  Extended pancreatic transection for secure pancreatic reconstruction during pancreaticoduodenectomy.

Authors:  Eun-Kyoung Jwa; Shin Hwang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.